Chemotherapy: can you have botox or filler?

· 4 min read

Editorial illustration about chemotherapy

Quick facts

Question
Chemotherapy and botox or filler
Usual approach
Postpone during treatment and coordinate with the oncology team
Reason
Low immunity, platelets and risk of infection
Who decides
Oncology team and qualified professional

The short answer: during chemotherapy, the usual approach is to postpone botox and filler and decide the return together with the oncology team. Immunity may be reduced, platelets may be low and the skin may be more fragile, which makes any injectable procedure riskier than it looks.

This page is for you to answer the patient who wants to "feel better" during treatment, without being cold, without promising anything and without taking on a decision that belongs to the oncologist.

Why the treatment weighs on the decision

Chemotherapy acts on fast-dividing cells, and that includes blood and defense cells. In many regimens, white blood cell and platelet counts drop at certain phases of the cycle, and the patient is more exposed to infection and bleeding. Harmonization creates small entry points in the skin and, in any patient, can cause bruising and swelling.

In someone who is immunosuppressed, a contaminated entry point is more likely to progress to infection, and a bruise can be larger and slower to clear. The skin may also be dry, sensitive or altered by the treatment. Together, these factors explain the recommendation to wait.

What differs between toxin and filler

Aspect Botulinum toxin Hyaluronic acid filler
Entry points Several, small Vary with the technique
Infection risk Exists, tied to breaking the skin Exists, and the product can act as a medium for biofilm
Bleeding risk Bruising possible Bruising possible, sometimes more extensive
Reversibility The effect fades on its own Can be dissolved with hyaluronidase

The difference does not change the general rule: neither is "safe" to do without coordination during active treatment. The patient may think botox, being quick, is harmless, and that perception needs to be gently corrected.

How to lead the conversation

The cancer patient often has a legitimate wish to care for their appearance and self-esteem. Answering only "you cannot" can sound harsh. A welcoming approach is to explain why, offer other compatible forms of care and leave the door open for later.

And after treatment?

The return is individual. It depends on the type of treatment, the time since the last session, the recovery of immunity and the team's guidance. Some patients also have skin and facial volume changes from the therapy or from weight loss, which alters the planning. See the reasoning on volume change in facial volume loss after weight loss.

When resuming, it is worth reassessing from scratch: a complete medical history, a new consent form and realistic expectations. The informed consent should record the cancer history.

Quick review questions

Compatible alternatives

Care that does not involve needles can be discussed with the patient's health team, such as guidance on sun protection and skin hydration. The harmonization professional should not prescribe or suggest anything that goes against the oncology guidance.

Summary

  • During chemotherapy, the usual approach is to postpone.
  • Low immunity and altered platelets raise the risks.
  • Clearance should involve the oncology team.
  • Be welcoming to the patient and record the guidance.
  • Decisions are up to the qualified professional, according to the rules of their professional council in Brazil, and the team that follows the patient.

For other health conditions, see facial radiotherapy and fillers and skin cancer and aesthetic procedures.

Frequently asked questions

Can someone on chemotherapy have botox?

Generally the approach is to postpone during treatment. Immunity may be low and platelets altered, and any injectable procedure should be coordinated with the oncology team.

What about filler during chemotherapy?

The prudent recommendation is the same: postpone. Entry points in an immunosuppressed patient raise the risk of infection, and bruising can be larger with low platelets.

When can I have it again after treatment?

The timing is set together with the oncologist, once the condition is stable and immunity has recovered. There is no single timeframe that suits everyone.

Can the professional clear it alone?

Ideally, clearance involves the team that follows the patient. The harmonization professional should not take on alone a decision that depends on the cancer situation.

Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.

Terms mentioned